A Study of Mechanistic Mapping of Novel SNPs to Male Breast Cancer

Overview

Journal Med Oncol

Publisher Springer

Specialty Oncology

Date 2019 Jun 17

PMID 31203460

Citations 4

Authors

Raman Preet Kaur

Vicky Kumar

Gowhar Shafi

Rajesh Vashistha

Mahesh Kulharia

Anjana Munshi

Affiliations

Soon will be listed here.

Abstract

Alterations in BRCA2, PALB2, CHEK2, and p53 genes have been identified for their association with male breast cancer in various studies. The incidence of male breast cancer in India is consistent with its global rate. The present study was carried out with an aim to evaluate the genetic alterations in male breast cancer patients from Malwa region of Punjab, India. Four male breast cancer patients belonging to different families were recruited from Guru Gobind Singh Medical College and Hospital, Faridkot, India. A total of 51 genes reported with implications in the pathogenesis of breast cancer were screened using next generation sequencing. Germline variations were found in BRCA1, BRCA2, PMS2, p53, and PALB2 genes, previously reported to be associated with MBC as well as FBC. In addition to these, 13 novel missense alterations were detected in eight genes including STK11, FZR1, PALB2, BRCA2, NF2, BAP1, BARD1, and CHEK2. Impact of these missense alterations on structure and function of protein was also analyzed through molecular dynamics simulation. Structural analysis of these single nucleotide polymorphisms (SNPs) revealed significant impact on the encoded protein functioning.

Citing Articles

Male Breast Cancer: Current Scenario and Future Perspectives.

Chidambaram A, Prabhakaran R, Sivasamy S, Kanagasabai T, Thekkumalai M, Singh A Technol Cancer Res Treat. 2024; 23:15330338241261836.

PMID: 39043043 PMC: 11271170. DOI: 10.1177/15330338241261836.

Male breast cancer: a 30 year retrospective analysis from a tertiary cancer care centre.

Soni A, Verma Y, Chauhan A, Kaur P, Kaushal V, Paul D Ecancermedicalscience. 2023; 17:1551.

PMID: 37377689 PMC: 10292857. DOI: 10.3332/ecancer.2023.1551.

Literature Review of as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers.

Alenezi W, Fierheller C, Recio N, Tonin P Genes (Basel). 2020; 11(8).

PMID: 32726901 PMC: 7464855. DOI: 10.3390/genes11080856.

Male Breast Cancer: Clinicopathological, Immunohistochemical and Radiological Study.

Hasbay B, Bolat F, Aytac H, Kus M, Pourbagher A Turk Patoloji Derg. 2020; 36(3):211-217.

PMID: 32525214 PMC: 10510604. DOI: 10.5146/tjpath.2020.01490.

References

Lovell S, Davis I, Arendall 3rd W, de Bakker P, Word J, Prisant M . Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins. 2003; 50(3):437-50. DOI: 10.1002/prot.10286. View

Hodgson N, Button J, Franceschi D, Moffat F, Livingstone A . Male breast cancer: is the incidence increasing?. Ann Surg Oncol. 2004; 11(8):751-5. DOI: 10.1245/ASO.2004.01.001. View

Tan Y, Raychaudhuri P, Costa R . Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes. Mol Cell Biol. 2006; 27(3):1007-16. PMC: 1800696. DOI: 10.1128/MCB.01068-06. View

Rai B, Ghoshal S, Sharma S . Breast cancer in males: a PGIMER experience. J Cancer Res Ther. 2007; 1(1):31-3. DOI: 10.4103/0973-1482.16087. View

Yoney A, Kucuk A, Unsal M . Male breast cancer: a retrospective analysis. Cancer Radiother. 2009; 13(2):103-7. DOI: 10.1016/j.canrad.2008.11.011. View

Shah P, Robbani I, Shah O . Clinicopathological study of male breast carcinoma: 24 years of experience. Ann Saudi Med. 2009; 29(4):288-93. PMC: 2841456. DOI: 10.4103/0256-4947.55314. View

Anderson W, Jatoi I, Tse J, Rosenberg P . Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol. 2009; 28(2):232-9. PMC: 2815713. DOI: 10.1200/JCO.2009.23.8162. View

Benkert P, Biasini M, Schwede T . Toward the estimation of the absolute quality of individual protein structure models. Bioinformatics. 2010; 27(3):343-50. PMC: 3031035. DOI: 10.1093/bioinformatics/btq662. View

Chikaraddi S, Krishnappa R, Deshmane V . Male breast cancer in Indian patients: is it the same?. Indian J Cancer. 2012; 49(3):272-6. DOI: 10.4103/0019-509X.104484. View

10.

Apostolou P, Fostira F . Hereditary breast cancer: the era of new susceptibility genes. Biomed Res Int. 2013; 2013:747318. PMC: 3618918. DOI: 10.1155/2013/747318. View

11.

Rizzolo P, Silvestri V, Tommasi S, Pinto R, Danza K, Falchetti M . Male breast cancer: genetics, epigenetics, and ethical aspects. Ann Oncol. 2013; 24 Suppl 8:viii75-viii82. DOI: 10.1093/annonc/mdt316. View

12.

Park J, Singh T, Nassar N, Zhang F, Freund M, Hanenberg H . Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair. Oncogene. 2013; 33(40):4803-12. PMC: 3994186. DOI: 10.1038/onc.2013.421. View

13.

Green A, Green H, Rehnberg M, Svensson A, Gunnarsson C, Jonasson J . Assessment of HaloPlex amplification for sequence capture and massively parallel sequencing of arrhythmogenic right ventricular cardiomyopathy-associated genes. J Mol Diagn. 2014; 17(1):31-42. DOI: 10.1016/j.jmoldx.2014.09.006. View

14.

Krieger E, Vriend G . New ways to boost molecular dynamics simulations. J Comput Chem. 2015; 36(13):996-1007. PMC: 6680170. DOI: 10.1002/jcc.23899. View

15.

Sundriyal D, Kotwal S, Dawar R, Parthasarathy K . Male Breast Cancer in India: Series from a Cancer Research Centre. Indian J Surg Oncol. 2016; 6(4):384-6. PMC: 4809860. DOI: 10.1007/s13193-015-0473-1. View

16.

Staruch R, Rouhani M, Ellabban M . The surgical management of male breast cancer: Time for an easy access national reporting database?. Ann Med Surg (Lond). 2016; 9:41-9. PMC: 4927636. DOI: 10.1016/j.amsu.2016.06.001. View

17.

Pritzlaff M, Summerour P, McFarland R, Li S, Reineke P, Dolinsky J . Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results. Breast Cancer Res Treat. 2016; 161(3):575-586. PMC: 5241330. DOI: 10.1007/s10549-016-4085-4. View

18.

Cabanillas R, Dineiro M, Castillo D, Pruneda P, Penas C, Cifuentes G . A novel molecular diagnostics platform for somatic and germline precision oncology. Mol Genet Genomic Med. 2017; 5(4):336-359. PMC: 5511795. DOI: 10.1002/mgg3.291. View

19.

Bell R, Barraclough R, Vasieva O . Gene Expression Meta-Analysis of Potential Metastatic Breast Cancer Markers. Curr Mol Med. 2017; 17(3):200-210. PMC: 5748874. DOI: 10.2174/1566524017666170807144946. View

20.

Herzig S, Shaw R . AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2017; 19(2):121-135. PMC: 5780224. DOI: 10.1038/nrm.2017.95. View